Abstract

P2-8-20 - Salvage line CPT-11 after failure of fluoropyrimidine and paclitaxel-based chemotherapy in advanced gastric cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Optimising treatment regimens for the management of advanced gastric cancer
R Wong ... D Cunningham
Annals of Oncology | VOL. 20
R Wong, et. al.R Wong ... D Cunningham
01 Apr 2009
A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy
Heung Moon Chang ... Yoon-Koo Kang
Cancer Chemotherapy and Pharmacology | VOL. 61
Heung Moon Chang, et. al.Heung Moon Chang ... Yoon-Koo Kang
23 May 2007
P1-034 - ARID1A expression in advanced gastric cancer: Correlation with clinical outcome and response to first-line chemotherapy
Fumiyoshi Fushimi ... Miyuki Kuwayama
Annals of Oncology | VOL. 27
Fumiyoshi Fushimi, et. al.Fumiyoshi Fushimi ... Miyuki Kuwayama
01 Nov 2016
Relationship between the fluorouracil pathway gene and effect of chemotherapy in advanced gastric cancer after surgery
...
-
, et. al. ...
28 Jun 2011
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: “ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe”, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
VP2-2024: Fuzuloparib with or without apatinib in HER2- metastatic breast cancer (mBC) patients (pts) with germline BRCA1/2 mutations (gBRCA1/2m): A randomized phase III trial
H Li ... E Song
Annals of Oncology | VOL. -
H Li, et. al.H Li ... E Song
01 May 2024
View more papers